Sarepta licenses therapy to boost gene therapies
Sarepta signs agreement with Hansa to use its treatment as part of a gene therapy treatment schedule.
Archives for July 6, 2020
J&J receives EU approval for Ebola vaccine
The company becomes the second to receive approval, behind Merck, for its Ebola vaccine.